If you need more lookups,
subscriptions start at $34 USD/month.
Eugen Leo Location
Bavaria, Germany
Eugen Leo Work
Chief Medical Officer @ (October 2018 - Present)
Founder and CEO @ (June 2009 - Present)
Associate Professor, Dpt. of Hematology, Medical Oncology and Rheumatology @ (January 2006 - Present)
Chief Medical Officer @ (June 2019 - December 2022)
Acting Chief Medical Officer @ (October 2017 - April 2019)
Chief Medical Officer @ Rigontec GmbH (January 2017 - December 2017)
Chief Medical Officer @ (August 2013 - October 2018)
Global Head, Early Clinical Development Oncology @ (October 2008 - May 2009)
Medical Leader, Early Clinical Development Oncology @ (August 2005 - August 2008)
Medical Director and Vice President @ (February 2003 - August 2005)
Resident and Attending Physician, Dpt. of Hematology, Medical Oncology and Rheumatology @ (January 2000 - January 2003)
Research Associate and Postdoctoral Fellow @ (January 1996 - January 2000)
Eugen Leo Education
University of Freiburg
Doctor of Medicine (Medicine)
1987-1994
Colorado State University
Master of Business Administration (Business)
1985-1989
Eugen Leo Skills
Biomarkers
Biopharmaceuticals
Biotechnology
Cancer
Clinical Development
Clinical Operations
Clinical Pharmacology
Clinical Research
Clinical Trials
Drug Development
Drug Discovery
Hematology
Immunology
Life Sciences
Lifesciences
Oncology
Oncology Clinical Research
Pharmaceutical Industry
Pharmacokinetics
Pharmacology
Translational Medicine
Translational Research
Eugen Leo Summary
Eugen Leo, based in Bavaria, Germany, is currently a Chief Medical Officer at CatalYm GmbH. Eugen Leo brings experience from previous roles at LEOConsulting, University of Heidelberg, T-knife and Imcheck Therapeutics. Eugen Leo holds a 1987 - 1994 Doctor of Medicine in Medicine @ University of Freiburg. With a robust skill set that includes Biomarkers, Biopharmaceuticals, Biotechnology, Cancer, Clinical Development and more. Eugen Leo has 2 emails on RocketReach.
Looking for a different Eugen Leo?
Find contact details for 700 million professionals.